This is due to their effectiveness in managing type 2 diabetes and promoting weight loss
Rotilio, G
More than one-in-four employers tightened utilization controls this year, or plan to in 2027, Mercer said
Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lilly's Mounjaro and Zepbound, are considered GLP-1 drugs
For many of us, that means becoming indifferent to sweet and fatty foods, leading to significant weight loss
Follow-up Re-check metabolic markers and IGF-1 after 6-8 weeks, with earlier review if GI symptoms, glucose symptoms, or fluid retention occur